Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.84 USD | +4.45% | +3.88% | -28.57% |
29/05 | Transcript : BridgeBio Pharma, Inc. - Special Call | |
28/05 | UBS Adjusts Price Target on BridgeBio Pharma to $47 From $51, Maintains Buy Rating | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BRIDGEBIO PHARMA, INC. | Biopharmaceuticals | +4.45% | +3.88% | -28.57% | +112.98% | - | 516.66Cr |
Technical Rankings Surperformance
- Stock Market
- Equities
- BBIO Stock
- Charts BridgeBio Pharma, Inc.
- Comparison Chart